The addition of FliC to the vaccine formulation (Groups 2 & 3) reduced antibody titres and survival when compared with Group 1, although this latter effect was just outside the conventional levels of significance ( p = 0.06).
← all phrases
“just outside the conventional levels of significance”
Sighted at
p=0.1076